Hippocampal volume reduction specific for later transition to psychosis or substance-associated effects?

Stefan Borgwardt; Renata Smieskova; Kerstin Bendfeldt; Eva Bühlmann; Gregor Berger; Jacqueline Aston; Ute Gschwandtner; Marlon Pflueger; Rolf Dieter Stieglitz; Anita Riecher-Rössler; Ernst Wilhelm Radue

Hippocampal volume reduction specific for later transition to psychosis or substance-associated effects?

Stefan Borgwardt^*, Renata Smieskova, Kerstin Bendfeldt, Eva Bühlmann, Gregor Berger, Jacqueline Aston, Ute Gschwandtner, Marlon Pflueger, Rolf Dieter Stieglitz, Anita Riecher-Rössler, Ernst Wilhelm Radue

^*Korrespondierende/r Autor/-in für diese Arbeit

Klinik für Psychiatrie und Psychotherapie

4 Zitate (Scopus)

Originalsprache	Englisch
Zeitschrift	Journal of Psychiatry and Neuroscience
Jahrgang	35
Ausgabenummer	3
Seiten (von - bis)	214-215
Seitenumfang	2
ISSN	1180-4882
Publikationsstatus	Veröffentlicht - 05.2010

Fördermittel

Competing interests: Dr. Borgwardt’s research was supported by a personal grant from the Swiss National Science Foundation (PBBSB-106936). The sponsor had no role in the intellectual work, writing of this letter, or the decision to submit this letter for publication. Dr. Berger has received speaker honoraria from AstraZeneca, Lilly, and Janssen-Cilag. None declared for all other authors.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen
SDG 10 – Weniger Ungleichheiten

Weitere Links

Link to publication in Scopus

Zitieren

@article{d881ae0ba4b6469cb8d369c9aef97338,

title = "Hippocampal volume reduction specific for later transition to psychosis or substance-associated effects?",

author = "Stefan Borgwardt and Renata Smieskova and Kerstin Bendfeldt and Eva B{\"u}hlmann and Gregor Berger and Jacqueline Aston and Ute Gschwandtner and Marlon Pflueger and Stieglitz, \{Rolf Dieter\} and Anita Riecher-R{\"o}ssler and Radue, \{Ernst Wilhelm\}",

note = "Funding Information: Competing interests: Dr. Borgwardt{\textquoteright}s research was supported by a personal grant from the Swiss National Science Foundation (PBBSB-106936). The sponsor had no role in the intellectual work, writing of this letter, or the decision to submit this letter for publication. Dr. Berger has received speaker honoraria from AstraZeneca, Lilly, and Janssen-Cilag. None declared for all other authors. ",

year = "2010",

month = may,

language = "English",

volume = "35",

pages = "214--215",

journal = "Journal of Psychiatry and Neuroscience",

issn = "1180-4882",